Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Large-scale functional characterization of low-density lipoprotein receptor gene variants improves risk assessment in cardiovascular disease

Mohammad Majharul Islam, Max Tamlander, Iryna Hlushchenko, Samuli Ripatti, View ORCID ProfileSimon G. Pfisterer
doi: https://doi.org/10.1101/2023.12.27.23299827
Mohammad Majharul Islam
1Department of Anatomy, Faculty of Medicine, University of Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Max Tamlander
2Institute for Molecular Medicine Finland, FIMM, HiLIFE, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iryna Hlushchenko
1Department of Anatomy, Faculty of Medicine, University of Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuli Ripatti
2Institute for Molecular Medicine Finland, FIMM, HiLIFE, University of Helsinki, Helsinki, Finland
3Clinicum, Department of Public Health, University of Helsinki, Helsinki, Finland
4Broad Institute of MIT and Harvard, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon G. Pfisterer
1Department of Anatomy, Faculty of Medicine, University of Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Simon G. Pfisterer
  • For correspondence: simon.pfisterer{at}helsinki.fi
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Aims Lack of functional information for low-density lipoprotein (LDL) receptor (LDLR) mutations limits the use of genetics for early diagnosis, risk assessment and clinical decision making in familial hypercholesterolemia (FH). The goal of this study was an in-depth and large-scale functional characterization of LDLR variants to overcome this problem.

Methods Open-source robotic tools were integrated with multiplexed high-content microscopy, image and data analysis into a novel semi-automated analysis pipeline for the characterization of LDLR variants to quantify LDL uptake, LDLR localization and expression.

Results 315 LDLR coding variants were functionally characterized in this study and collapsed into four functional groups based on their residual LDL uptake activity (“Loss-of-function”, 0-10% activity; “defective”, 10-30%; “mildly-defective”, 30-70%; and “non-defective”, > 90%). Integration of the activity groups with whole-exome sequencing and clinical data from UK biobank demonstrated that considering LDLR activity levels improved risk assessment in dyslipidaemia and cardiovascular disease (CVD). Individuals carrying LDLR variants from the loss-of-function and defective groups displayed increased odds ratios for CVD (OR=6.1, 95% CI = 1.5 - 24.4; OR = 1.83, 95% CI = 1.2 - 2.7) as compared to the non-defective group. Also, plasma LDL-cholesterol, utilization of lipid-lowering drugs and combination therapy were higher in the loss-of-function (OR = 15.4, 95% CI = 3.8 - 61.7; OR = 7.6, 95% CI = 1.8 - 31.8; OR = 96.8, 95% CI = 22.6 - 414.1), defective (OR = 5.9, 95% CI = 4.1 - 8.6; OR = 3.5, 95% CI = 2.5 - 4.9; OR = 15.6, 95% CI = 8.4 - 29.1) and mildly-defective group (OR = 2.0, 95% CI = 1.5 - 2.7; OR = 2.0, 95% CI = 1.6 - 2.4; OR = 1.9, 95% CI = 1.0 - 3.4) as compared to the non-defective group. Especially, the loss-of-function group displayed higher CVD risk, increased LDL-C and combination therapy usage as compared to the ClinVar pathogenic group for the same subjects. Furthermore, the functional data indicates that prediction tools tend to overestimate the fraction of pathogenic LDLR variants.

Conclusion Systematic functional data for LDLR variants paves the way for improved diagnosis, risk assessment and treatment optimization for FH patients, enabling a better utilization of genetic data in clinical decision making.

Translational perspective A loss-of-function LDLR variant leads to lifelong exposure of elevated LDL-C. Whilst sequencing of the LDLR gene is included in the genetic assessment of FH patients, most LDLR variants lack information about functional consequences at the cellular level. This limits the utility of genetic tools in the diagnosis and treatment of FH. This study overcomes this problem, providing functional information for a large set of LDLR variants. Integration with genetic and clinical data from UK biobank enables links between functional and clinical effects, making it easier to diagnose FH and estimate a patient’s cardiovascular risk.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Grants from the Academy of Finland 328861 and 325040, Business Finland (Research to Business) 1821/31/2021, Magnus Ehrnrooth and the Foundation for Cardiovascular Research to S.G.P. Grants from Academy of Finland Center of Excellence in Complex Disease Genetics 312062, Academy of Finland 285380, the Finnish Foundation for Cardiovascular Research and the Sigrid Juselius Foundation to S.R. Funding from the Doctoral Programme in Population Health, University of Helsinki to M.T.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This project has been granted access to use the UK Biobank resource. https://www.ukbiobank.ac.uk/ Ethical application has been granted to UK Biobank. Application Number: 87446

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • This study was conducted at the Department of Anatomy, Faculty of Medicine, University of Helsinki, Finland.

  • The abstract was updated, as initially an older version was uploaded in the online form.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

https://www.ukbiobank.ac.uk/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted December 28, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Large-scale functional characterization of low-density lipoprotein receptor gene variants improves risk assessment in cardiovascular disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Large-scale functional characterization of low-density lipoprotein receptor gene variants improves risk assessment in cardiovascular disease
Mohammad Majharul Islam, Max Tamlander, Iryna Hlushchenko, Samuli Ripatti, Simon G. Pfisterer
medRxiv 2023.12.27.23299827; doi: https://doi.org/10.1101/2023.12.27.23299827
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Large-scale functional characterization of low-density lipoprotein receptor gene variants improves risk assessment in cardiovascular disease
Mohammad Majharul Islam, Max Tamlander, Iryna Hlushchenko, Samuli Ripatti, Simon G. Pfisterer
medRxiv 2023.12.27.23299827; doi: https://doi.org/10.1101/2023.12.27.23299827

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cardiovascular Medicine
Subject Areas
All Articles
  • Addiction Medicine (433)
  • Allergy and Immunology (758)
  • Anesthesia (222)
  • Cardiovascular Medicine (3307)
  • Dentistry and Oral Medicine (365)
  • Dermatology (282)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1174)
  • Epidemiology (13391)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5167)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3281)
  • Health Policy (1144)
  • Health Systems and Quality Improvement (1196)
  • Hematology (432)
  • HIV/AIDS (1021)
  • Infectious Diseases (except HIV/AIDS) (14647)
  • Intensive Care and Critical Care Medicine (914)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (525)
  • Neurology (4941)
  • Nursing (262)
  • Nutrition (733)
  • Obstetrics and Gynecology (887)
  • Occupational and Environmental Health (796)
  • Oncology (2526)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (546)
  • Pediatrics (1303)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4221)
  • Public and Global Health (7522)
  • Radiology and Imaging (1710)
  • Rehabilitation Medicine and Physical Therapy (1016)
  • Respiratory Medicine (981)
  • Rheumatology (480)
  • Sexual and Reproductive Health (499)
  • Sports Medicine (425)
  • Surgery (550)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (206)